Please login to the form below

Not currently logged in
Email:
Password:

Illumina

This page shows the latest Illumina news and features for those working in and with pharma, biotech and healthcare.

Loxo, Bayer get FDA okay for biomarker-driven cancer drug

Loxo, Bayer get FDA okay for biomarker-driven cancer drug

To try to address the diagnostic issue, Loxo formed a partnership earlier this year with Illumina to develop a simple test – called TruSight Tumour 170 – that will use sequencing to identify

Latest news

More from news
Approximately 7 fully matching, plus 11 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2017 Deal Watch January 2017

    IBM Watson Health/ Illumina. Partnership to integrate Watson for Genomics into Illumina's BaseSpace Sequence Hub and tumour sequencing process to expand access to genomic data.

  • Digital: Fallacy or the Future Face of Pharma Marketing? Digital: Fallacy or the Future Face of Pharma Marketing?

    Speakers. Dan Coffin, Global Head of Illuminas Health. Dan now heads up the global pharmaceutical arm of Illuminas and brings an interesting mix of experiences having worked agency side at Isis

  • Pharma deals during July 2013 Pharma deals during July 2013

    Roche, rumoured to be interested in Alexion, may still be smarting from the battle to try and take over Illumina last year.

  • What can pharma learn from Olympic sports coverage? What can pharma learn from Olympic sports coverage?

    So where could Roche go next? With its unsuccessful takeover bid for Illumina, it could be a move into genetic sequencing to augment their oncology capability and more besides.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

  • Illumina expands board of directors Illumina expands board of directors

    John Thompson brings experience from IBM and Microsoft. San Diego, US-based Illumina has appointed John Thompson to its board of directors. ... Francis de Souza, president and chief executive of Illumina, said: “John brings a great breadth of knowledge

  • GlobalData makes Americas appointment GlobalData makes Americas appointment

    He has spent 18 years in varous positions in the life sciences consulting industry, including roles at, Bionest Partners, IMS Management Consulting, and Illumina Inc.

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics